Evidence map›Paper›PMID 37822892›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2023

Chemical Composition and Antifungal and Antibiofilm Effects of

Zahra Zareshahrabadi, Mohammad Jamal Saharkhiz, Maryam Izadpanah, Aida Iraji, Maryam Emaminia, Maryam Motealeh, Hossein Khodadadi, Kamiar Zomorodian

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zahra ZareshahrabadiBasic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0003-0314-7502
Mohammad Jamal SaharkhizMedicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam IzadpanahDepartment of Parasitology and Mycology, Shiraz University of Medical Sciences, Shiraz, Iran.
Aida IrajiResearch Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-8442-2205
Maryam EmaminiaShiraz University of Medical Sciences, Shiraz, Iran.
Maryam MotealehCellular and Molecular Biology-Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Hossein KhodadadiDepartment of Parasitology and Mycology, Shiraz University of Medical Sciences, Shiraz, Iran.
Kamiar ZomorodianBasic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-3338-7112
Shiraz University of Medical Sciences · IRShiraz University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: The chemical composition of the Results: Based on GC/MS analysis, the major components of the Conclusion: Considering the significant antifungal activities of these essential oils, they can be considered a potential source for formulating novel agents to control fungal infections.

Identifiers

PMID37822892
PMCPMC10564579
OpenAlexW4387298376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.